Insights from Drosophila on Aβ- and tau-induced mitochondrial dysfunction: mechanisms and tools

Insights from Drosophila on Aβ- and tau-induced mitochondrial dysfunction: mechanisms and tools

Alzheimer’s disease (AD) is the most prevalent neurodegenerative dementia in older adults worldwide. Sadly, there are no disease-modifying therapies available for treatment due to the multifactorial complexity of the disease. AD is pathologically characterized by extracellular deposition of amyloid...

Full description

Bibliographic Details
Main Authors:	Vanlalrinchhani Varte, Jeremy W. Munkelwitz, Diego E. Rincon-Limas
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Neuroscience
Subjects:	Alzheimer’s disease amyloid beta Drosophila mitochondria neurodegeneration tau
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2023.1184080/full

Similar Items

Toxicities of amyloid-beta and tau protein are reciprocally enhanced in the Drosophila model
by: Zhen-Dong Sun, et al.
Published: (2022-01-01)

secHsp70 as a tool to approach amyloid-β42 and other extracellular amyloids
by: Lorena De Mena, et al.
Published: (2017-07-01)

TauLUM, an in vivo Drosophila sensor of tau multimerization, identifies neuroprotective interventions in tauopathy
by: Simon A. Levy, et al.
Published: (2022-09-01)

Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
by: Zdeněk Fišar
Published: (2022-11-01)

Mitochondrial Manipulation and the Quest for Alzheimer's Treatments
by: Russell H. Swerdlow
Published: (2015-04-01)

Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease
by: Cécile Tissot, et al.
Published: (2021-01-01)

Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration
by: María J. Pérez, et al.
Published: (2018-07-01)

Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
by: Alejandro R Roda, et al.
Published: (2022-01-01)

Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity
by: Arun Upadhyay, et al.
Published: (2023-09-01)

Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer’s Disease
by: Lauren H. Fairley, et al.
Published: (2021-02-01)

Distinctive alteration in the expression of autophagy genes in Drosophila models of amyloidopathy and tauopathy
by: Mehrnaz Haghi, et al.
Published: (2020-10-01)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
by: Daniel Lamontagne-Kam, et al.
Published: (2023-07-01)

Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation
by: Woo Shik Shin, et al.
Published: (2019-10-01)

Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness
by: Seyed Hani Hojjati, et al.
Published: (2023-01-01)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
by: P. Hemachandra Reddy, et al.
Published: (2019-05-01)

Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
by: Josef Marksteiner, et al.
Published: (2022-09-01)

Aß40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aß42 toxicity in Drosophila
by: Lorena De Mena, et al.
Published: (2020-10-01)

Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
by: Hong-Qi Yang, et al.
Published: (2012-10-01)

Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease?
by: Sonja Prpar Mihevc, et al.
Published: (2019-06-01)

Different Amyloid-β Self-Assemblies Have Distinct Effects on Intracellular Tau Aggregation
by: Woo Shik Shin, et al.
Published: (2019-11-01)

An AMPK-dependent regulatory pathway in tau-mediated toxicity
by: Alessia Galasso, et al.
Published: (2017-10-01)

Oral Administration of Probiotic Bacteria Alleviates Tau Phosphorylation, Aβ Accumulation, Microglia Activation, and Memory Loss in 5xFAD Mice
by: Yeong Jin Kim, et al.
Published: (2024-02-01)

The role of type 2 diabetes in neurodegeneration
by: Giuseppe Verdile, et al.
Published: (2015-12-01)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
by: Juanjuan Zhao, et al.
Published: (2017-07-01)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
by: Jurre den Haan, et al.
Published: (2018-12-01)

Advances and considerations in AD tau-targeted immunotherapy
by: Alice Bittar, et al.
Published: (2020-02-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01)

Amyloid β and tau pathology in brains of aged pinniped species (sea lion, seal, and walrus)
by: Yuta Takaichi, et al.
Published: (2021-01-01)

Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice
by: Hee-Jeong Choi, et al.
Published: (2022-07-01)

LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent
by: Daniela Puzzo, et al.
Published: (2017-07-01)

Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease
by: Mar Cuadrado-Tejedor, et al.
Published: (2021-11-01)

GSK3 and Alzheimer's disease: facts & fiction …
by: Fred eVanleuven
Published: (2011-08-01)

Mitochondria Dysfunction in Frontotemporal Dementia/Amyotrophic Lateral Sclerosis: Lessons From Drosophila Models
by: Sharifah Anoar, et al.
Published: (2021-11-01)

A systematic review for the development of Alzheimer’s disease in in vitro models: a focus on different inducing agents
by: Manisha Prajapat, et al.
Published: (2023-12-01)

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
by: Franc Llorens, et al.
Published: (2017-09-01)

Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology
by: Noemi Esteras, et al.
Published: (2020-09-01)

New Features about Tau Function and Dysfunction
by: Miguel Medina, et al.
Published: (2016-04-01)

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
by: Kyu Hwan Shim, et al.
Published: (2022-12-01)

Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice
by: Mariana Vargas-Caballero, et al.
Published: (2017-04-01)

Neurotrophin receptor p75 mediates amyloid β-induced tau pathology
by: Lin-Lin Shen, et al.
Published: (2019-12-01)